Brief: Vera Therapeutics Q1 EPS USD -0.81 Vs. IBES Estimate USD -0.74
May 06 (Reuters) - Vera Therapeutics Q1 operating expenses USD 57.194 million. Q1 operating income USD -57.194 million vs. IBES estimate USD -51 million Q1 net income USD -51.694 million vs. IBES estimate USD -45.3 million
Recent news on Vera Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells Fargo
U.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Sysco
Vera Therapeutics gains after kidney disease drug meets goals in confirmatory trial